The hot topic on the ASX

Posted 15 May 2024 AM

Manufacturing has been a hot topic on the ASX this week with two companies signing deals while another scales up production.

Sydney-based Noxopharm announced it will increase manufacture of its preclinical lupus medication SOF-SKN 100-fold in readiness for clinical trials.

To see the whole article, please login

Popular

Bracing for a $100M revenue hit

$30M quarterly sales left behind

TGA first to add new mRNA jab AE

Thumbs down for pharma websites

Latest Jobs

Commercial Analyst

Senior Customer Service Representative

Account Manager

GP Sales Representative

See all...

Pharma in Focus Jobs

Sales & Customer Relations (27)

Clinical & Medical, R&D (18)

Regulatory, Pharmacovigilance & QA (7)

Other (25)

MORE NEWS

Email this article to a friend

From:

Subject

Friend's email

Message to go with the article

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.

Skip password for now